Outcometrix is a consulting firm specializing in measurement strategy and regulatory communication related to the use of clinical outcome assessments (COAs) for constructing endpoints in clinical trials. We help pharmaceutical sponsors with COA instrument selection, literature and label reviews, COA protocol integration, research design and reporting, and scientific communication. 

The name Outcometrix is a stylized portmanteau originating from the words outcome (something that happens as a result of an activity or process) and metrics (a method of measuring something).  The name represents not only what we do, but also the modern approach we take to solving problems.